Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06476548 · ClinicalTrials.gov registry record · Phase 1
Mindfulness-Based Ecological Momentary Intervention For Smoking Cessation Among Cancer Survivors
A Phase 1 study, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- Completed
- Registry status
- Phase 1
- Development phase
- 12
- Enrollment target
NCT06476548 is a Phase 1 study that has completed, run by H. Lee Moffitt Cancer Center and Research Institute. The registered enrollment target is 12 participants.
The verdict
NCT06476548, a Phase 1 study, has completed, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 12 participants
- Enrollment target
Study Summary
The purpose of the study is to obtain feedback on a new quit-smoking treatment among individuals with a cancer diagnosis using a prototype app we developed.
Interventions
- DEVICE EMI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2024-06-12 |
| Est. Completion | 2024-08-26 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06476548
The ClinicalTrials.gov registry entry for NCT06476548 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is H. Lee Moffitt Cancer Center and Research Institute, which has 502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which EMI is the first listed.
NCT06476548 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06476548 about?
NCT06476548 is a clinical study titled "Mindfulness-Based Ecological Momentary Intervention For Smoking Cessation Among Cancer Survivors". The purpose of the study is to obtain feedback on a new quit-smoking treatment among individuals with a cancer diagnosis using a prototype app we developed.
What is the current status of trial NCT06476548?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 12 participants. The study started on 2024-06-12. Estimated completion is 2024-08-26.
What interventions are being tested in trial NCT06476548?
The interventions under investigation include: EMI (DEVICE).
Who is sponsoring clinical trial NCT06476548?
This trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute, which has 502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.